Loading...

IVF INVO FERTILITY INC Company Mergers 8-K Filing

NV F

VF

INVO FERTILITY INC

(IVF)

2023 8-K

Show Summary

Summary

Debt Restructuring

Financial Results Update

Equity Offerings

Equity Offerings

Reverse Stock Split

Asset Acquisitions

Divestment of Assets

Divestment of Assets

Financial Statements

Equity Offerings

Equity Offerings

Financial Statements

Delisting Notice

Annual Meeting Results

Nasdaq Compliance

Stockholder Meeting Postponed

Investor Update

Merger Agreement

Nasdaq Compliance

Merger Completion

Cash Advance Agreement

Nasdaq Compliance Notice

Merger Agreement Update

Financial Results

Convertible Note Extension

Financial Results Announcement

Merger Agreement Amendment

Termination of Lease Agreem...

Warrant Issuance and Price ...

Financial Results Announcement

Purchase Agreement

Purchase Agreement with Tri...

Agreement for Purchase and ...

Funding Shortfall

Correction and Extension

Agreement for Purchase of S...

Merger Agreement Amendment

Amendment to Common Stock P...

Amendment to Bylaws

Compliance Regained

Share Exchange Agreement

Financial Results Announcement

Exchange Offer for Warrants

Waiver Solicitation for Pro...

Merger Agreement

Annual Meeting Rescheduled

Amendment to Articles of In...

Nasdaq Compliance Extension...

Earnings Reports

Agreement with Merchant

Financial Results Announcement

Acquisition of Clinic

Securities Purchase Agreement

Extension of Closing of Ass...

Reverse Stock Split

Investor Meetings

Debt-Equity Swaps

Financial Results Announcement

Financial Results Announcement

Resignation of Director

Financial Results Announcement

Securities Purchase Agreement

Securities Purchase Agreeme...

Acquisition of Wisconsin Fe...

Private Placement of Debent...

Private Placement and Equit...

Delisting Notice

Securities Purchase Agreements

Distribution Agreement in T...

External Links:

INVO Bioscience, Inc. filed a Form 8-K to disclose the execution of a Share Exchange Agreement with Cytovia Therapeutics Holdings, Inc., resulting in an increase in stockholders equity of $6,000,000 and compliance with Nasdaq listing criteria.

AI Assistant

INVO FERTILITY INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.